PMC:7283670 / 124130-124362 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T676","span":{"begin":44,"end":48},"obj":"Disease"},{"id":"T677","span":{"begin":163,"end":179},"obj":"Disease"}],"attributes":[{"id":"A676","pred":"mondo_id","subj":"T676","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A677","pred":"mondo_id","subj":"T677","obj":"http://purl.obolibrary.org/obo/MONDO_0005108"}],"text":"Other candidates for possible management of SARS‐CoV‐2 include Leronlimab and Galidesivir, both of which have been of clinical value in treatment of several fatal viral infections, and were shown to improve the survival of patients."}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T18","span":{"begin":163,"end":179},"obj":"http://purl.obolibrary.org/obo/GO_0016032"}],"text":"Other candidates for possible management of SARS‐CoV‐2 include Leronlimab and Galidesivir, both of which have been of clinical value in treatment of several fatal viral infections, and were shown to improve the survival of patients."}

{"project":"LitCovid-sentences","denotations":[{"id":"T1032","span":{"begin":0,"end":232},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Other candidates for possible management of SARS‐CoV‐2 include Leronlimab and Galidesivir, both of which have been of clinical value in treatment of several fatal viral infections, and were shown to improve the survival of patients."}

{"project":"LitCovid-PubTator","denotations":[{"id":"2544","span":{"begin":44,"end":54},"obj":"Species"},{"id":"2545","span":{"begin":223,"end":231},"obj":"Species"},{"id":"2549","span":{"begin":63,"end":73},"obj":"Chemical"},{"id":"2550","span":{"begin":78,"end":89},"obj":"Chemical"},{"id":"2552","span":{"begin":163,"end":179},"obj":"Disease"}],"attributes":[{"id":"A2544","pred":"tao:has_database_id","subj":"2544","obj":"Tax:2697049"},{"id":"A2545","pred":"tao:has_database_id","subj":"2545","obj":"Tax:9606"},{"id":"A2549","pred":"tao:has_database_id","subj":"2549","obj":"MESH:C420063"},{"id":"A2550","pred":"tao:has_database_id","subj":"2550","obj":"MESH:C517546"},{"id":"A2552","pred":"tao:has_database_id","subj":"2552","obj":"MESH:D001102"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Other candidates for possible management of SARS‐CoV‐2 include Leronlimab and Galidesivir, both of which have been of clinical value in treatment of several fatal viral infections, and were shown to improve the survival of patients."}